EUVIMEDEUVIMED entdecken
Crossref

Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM

Melissa Razo-Azamar, Rafael Nambo-Venegas, Iván Rafael Quevedo, Gregorio Juárez-Luna, Carlos Salomon iD, Martha Guevara-Cruz iD, Berenice Palacios-González iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Melissa Razo-Azamar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Envejecimiento Saludable del Instituto Nacional de Medicina Genómica (INMEGEN) en el Centro de Investigación sobre Envejecimiento (CIE…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Exosomes, Insulin-Secreting Cells, Placenta. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Instituto Nacional de Medicina Genómica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Pancreatic β-cell function impairment is a key mechanism for developing gestational diabetes mellitus (GDM). Maternal and placental exosomes regulate maternal and placental responses during hyperglycemia. Studies have associated exosomal micro-RNAs (miRNAs) with GDM development. To date, no studies have been reported that evaluate the profile of miRNAs present in maternal and placental exosomes in the early stages of gestation from pregnancies that develop GDM.

Objective

We assessed whether early-pregnancy serum maternal and placenta-derived exosomes miRNA profiles vary according to pancreatic β-cell function in women who will develop GDM.

Methods

A prospective nested case–control study was used to identify exosomal miRNAs that vary in early-pregnancy stages (<18 weeks of gestation) from women with normoglycemia and those who developed GDM based on their pancreatic β-cell function using the homeostasis model assessment of pancreatic β-cell function (HOMA-%β) index. Early-pregnancy serum maternal and placenta-derived exosomes were isolated to obtain miRNA profiles. Potential target and pathway analyses were performed to identify molecular and metabolic pathways associated with the exosomal miRNAs identified.

Results

In early-pregnancy stages, serum maternal exosome size and concentration are modified in GDM group and fluctuate according to HOMA-%β index. Serum maternal exosomal hsa-miR-149-3p and hsa-miR-455-3p in GDM are related to insulin secretion and signaling, lipolysis, and adipocytokine signaling. Early-pregnancy serum placenta-derived exosomes hsa-miR-3665 and hsa-miR-6727-5p in GDM are related to regulating genes involved in response to immunological tolerance of pregnancy and pathways associated with placental dysfunction.

Conclusion

Early serum exosomal miRNAs differ depending on their origin (maternal or placental) and pancreatic β-cell function. This research provides insights into the interactions between maternal and placental exosomal miRNAs and may have implications for identifying potential biomarkers or therapeutic targets for GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalExosomesInsulin-Secreting CellsPlacentaMicroRNAsHumansFemalePregnancyAdultCase-Control StudiesProspective StudiesPregnancy Trimester, First

Stichwörter der Autor:innen

exosomesgestational diabetes mellitusmiRNAspancreatic β-cell functionplacenta

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Laboratorio de Envejecimiento Saludable del Instituto Nacional de Medicina Genómica (INMEGEN) en el Centro de Investigación sobre Envejecimiento (CIE-CINVESTAV Sede Sur), 14330 CDMX, México.
  • Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14080 CDMX, México.
  • Laboratorio de Bioquímica de Enfermedades Crónicas Instituto Nacional de Medicina Genómica (INMEGEN), 14610 CDMX, México.
  • Departamento de Ingeniería Química Industrial y de Alimentos (DIQIA), Universidad Iberoamericana Ciudad de México (UIA), 01219 CDMX, México.
  • Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia.
  • Departamento de Investigación, Postgrado y Educación Continua (DIPEC), Facultad de Ciencias de la Salud, Universidad del Alba, 8320000 Santiago, Chile.

ORCID-Profile: Carlos Salomon, Martha Guevara-Cruz, Berenice Palacios-González

Förderung

  • Instituto Nacional de Medicina Genómica

Zitieren

APA

Razo-Azamar, M., Nambo-Venegas, R., Quevedo, I. R., Juárez-Luna, G., Salomon, C., Guevara-Cruz, M., & Palacios-González, B. (2024). Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad751

Vancouver

Razo-Azamar M, Nambo-Venegas R, Quevedo IR, Juárez-Luna G, Salomon C, Guevara-Cruz M, et al. Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad751

BibTeX
@article{RazoAzamar2024,
  author = {Razo-Azamar, Melissa and Nambo-Venegas, Rafael and Quevedo, Iván Rafael and Juárez-Luna, Gregorio and Salomon, Carlos and Guevara-Cruz, Martha and Palacios-González, Berenice},
  title = {Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad751}
}
Kostenlos starten →